Chronic sclerosing sialadenitis
ICD-10 K11.2·ICD-11 DA04.2.5

Treatment of Chronic Sclerosing Sialadenitis: What Are the Options?

Chronic sclerosing sialadenitis is a condition involving progressive fibrotic changes in a salivary gland, producing a firm, enlarging swelling that can closely mimic a malignant tumour on clinical examination. Establishing a definitive diagnosis and achieving reduction of the gland swelling are the central clinical goals.

Shrinking of the salivary gland swelling and resolution of the associated mass.
Management may involve either a surgical or a non-surgical route depending on the clinical picture. A surgical approach addresses both diagnosis and treatment simultaneously; a non-surgical approach using a specific systemic agent class has also shown efficacy in reducing glandular enlargement. The choice between these pathways — and the specific protocol — requires structured evaluation.

The complete evidence-based regimen, including the full decision pathway, is available via the structured protocol below.

References
DOI: 10.4149/bll_2013_009
  • Most commonly the mass is surgically excised, as it is difficult to differentiate it from a malignancy.
  • However, based on immunological findings recently implicated in its development, administration of steroids has been shown to be effective in shrinking such salivary swellings.
  • We think, that excision of the affected gland should be performed for definitive diagnosis and treatment of chronic sclerosing sialadenitis.
  • Surgical excision of the affected gland is a safe operation and seems to be a definitive treatment of chronic sclerosing sialadenitis.
View source ↗